Genesis Molecular AI · 12 hours ago
Head of Platform Engineering
Genesis Molecular AI is at the frontier of applying large-scale AI to drug discovery, and they are seeking a Head of Platform Engineering to lead their infrastructure. This role involves owning the platform and infrastructure strategy, designing systems for large-scale AI workloads, and mentoring a high-impact engineering team.
Artificial Intelligence (AI)BiotechnologyInformation Technology
Responsibilities
Own the end-to-end platform and infrastructure strategy supporting data, training, and large-scale inference
Design and operate systems for large-scale AI workloads, with strong judgment around build vs. buy decisions
Navigate infrastructure complexity across the full lifecycle: data ingestion and storage, distributed training, evaluation, and production inference
Build, lead, and mentor a high-impact platform engineering team
Stay hands-on when needed. This is a leadership role for someone who is comfortable diving deep into technical details and execution
Qualification
Required
Proven experience designing and operating infrastructure for AI training and inference at scale
Strong systems thinking and the ability to reason about tradeoffs across performance, cost, reliability, and velocity
Experience leading teams in fast-moving environments, with a startup mindset
Comfort operating across abstraction layers, from cloud and hardware to ML platforms and developer tooling
Preferred
Prior experience in AI for biology or drug discovery is not required, but curiosity and willingness to learn are essential
Company
Genesis Molecular AI
Genesis Therapeutics unifies AI and biotech to accelerate the discovery of new medicines.
H1B Sponsorship
Genesis Molecular AI has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (3)
2024 (1)
2023 (1)
2022 (1)
Funding
Current Stage
Growth StageTotal Funding
$256.1MKey Investors
Andreessen HorowitzRock Springs Capital
2023-08-21Series B· $200M
2020-12-02Series A· $52M
2020-04-01Series Unknown
Recent News
Genetic Engineering News
2025-12-10
MIT Technology Review
2025-11-27
Company data provided by crunchbase